Saundersblog.com

Once again, it seems to be the Chinese involved in a consumer product recall. This time, it's Baxter Healthcare's Heparin, a blood thinner widely used by patients in this country. The FDA has admitted that the plant should have been inspected, in fact, it was scheduled to be inspected, but it was not inspected. The FDA attributes the non-inspection to human error. This past Monday, the company announced it was suspending production of Heparin because of 350 reactions (including 4 deaths) linked to the drug. 40% of the reactions were considered serious by the FDA. Symptoms include stomach pain, vomiting and diarrhea, low blood pressure, speeding heartbeats and fainting.

Please be sure to visit our Defibrillator Information Website with up To the Minute Sprint Fidelis Lead Class Action Attorney and Medtronic Lawyer Lawsuit news and information regarding the Sprint Fidelis Defibrillator Lead Lawsuit.

Sprint Fidelis Lead Recall Lawyer Page On Our Main Website

http://www.fda.gov/cder/drug/infopage/heparin/heparinQA.htm

You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/503 .